Luca Scafuri

574 total citations
18 papers, 240 citations indexed

About

Luca Scafuri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Luca Scafuri has authored 18 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Luca Scafuri's work include Cancer Immunotherapy and Biomarkers (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Luca Scafuri is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Luca Scafuri collaborates with scholars based in Italy, United States and Russia. Luca Scafuri's co-authors include Felice Crocetto, Carlo Buonerba, Matteo Ferro, Giuseppe Di Lorenzo, Ciro Imbimbo, Pasquale Dolce, Giuseppe Lucarelli, Sabino De Placido, Biagio Barone and Antonio Verde and has published in prestigious journals such as Nutrients, Cancers and Frontiers in Oncology.

In The Last Decade

Luca Scafuri

12 papers receiving 238 citations

Peers

Luca Scafuri
Brian Hemendra Ramnaraign United States
Sunyi Ye China
Zonglin Li China
Jinhui Wang China
Ming‐Jenn Chen Taiwan
Fundagül Andiç Türkiye
Guiyi Ji China
Lili Lu China
Mohammed Safi China
Brian Hemendra Ramnaraign United States
Luca Scafuri
Citations per year, relative to Luca Scafuri Luca Scafuri (= 1×) peers Brian Hemendra Ramnaraign

Countries citing papers authored by Luca Scafuri

Since Specialization
Citations

This map shows the geographic impact of Luca Scafuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Scafuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Scafuri more than expected).

Fields of papers citing papers by Luca Scafuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Scafuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Scafuri. The network helps show where Luca Scafuri may publish in the future.

Co-authorship network of co-authors of Luca Scafuri

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Scafuri. A scholar is included among the top collaborators of Luca Scafuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Scafuri. Luca Scafuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lorenzo, Giuseppe Di, Carlo Buonerba, Antonio Tufano, et al.. (2025). Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle. Complementary Medicine Research. 32(2). 1–13.
2.
Scafuri, Luca, Carlo Buonerba, Oriana Strianese, et al.. (2025). Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review. Nutrients. 17(6). 981–981. 3 indexed citations
3.
4.
5.
Buonerba, Carlo, Luca Scafuri, Rossella Di Trolio, et al.. (2024). Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL. Oncology and Therapy. 13(1). 233–249.
6.
Miglietta, Federica, Carmine De Angelis, Emilio Bria, et al.. (2024). Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients. The Breast. 75. 103713–103713. 2 indexed citations
7.
Ingenito, Concetta, et al.. (2023). PREVES: A Population-Based Survey Focused on Cancer and Nutrition. Oncology. 101(6). 369–374. 2 indexed citations
8.
Crocetto, Felice, Matteo Ferro, Carlo Buonerba, et al.. (2023). Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone. Critical Reviews in Oncology/Hematology. 188. 104059–104059. 20 indexed citations
9.
Lorenzo, Giuseppe Di, Domenico Bilancia, Rossella Di Trolio, et al.. (2023). A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario. Oncology and Therapy. 12(1). 147–155.
10.
Barone, Biagio, Armando Calogero, Luca Scafuri, et al.. (2022). Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review. Cancers. 14(10). 2545–2545. 44 indexed citations
11.
Lorenzo, Giuseppe Di, Concetta Ingenito, Claudia Ferrara, et al.. (2022). The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial. Oncology. 100(9). 512–518. 6 indexed citations
12.
Crocetto, Felice, Erika Di Zazzo, Carlo Buonerba, et al.. (2021). Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature. Nutrients. 13(11). 3750–3750. 40 indexed citations
13.
Lorenzo, Giuseppe Di, Concetta Ingenito, Claudia Ferrara, et al.. (2021). The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study. Oncology. 100(9). 505–511.
14.
Buonerba, Carlo, Matteo Ferro, Pasquale Dolce, et al.. (2020). Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 151. 102992–102992. 36 indexed citations
15.
Terracciano, Daniela, Carlo Buonerba, Luca Scafuri, et al.. (2020). Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic. Frontiers in Oncology. 10. 2 indexed citations
16.
Ferro, Matteo, Giuseppe Lucarelli, Felice Crocetto, et al.. (2020). First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings. Critical Reviews in Oncology/Hematology. 157. 103198–103198. 36 indexed citations
17.
Buonerba, Carlo, Pasquale Dolce, Luca Scafuri, et al.. (2020). Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers. 12(2). 408–408. 32 indexed citations
18.
Buonerba, Carlo, Pasquale Dolce, Martina Pagliuca, et al.. (2019). Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis. Cancers. 11(9). 1259–1259. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Hemendra Ramnaraign Breakdown of academic impact, for papers by Sunyi Ye Breakdown of academic impact, for papers by Zonglin Li Breakdown of academic impact, for papers by Jinhui Wang Breakdown of academic impact, for papers by Ming‐Jenn Chen Breakdown of academic impact, for papers by Fundagül Andiç Breakdown of academic impact, for papers by Guiyi Ji Breakdown of academic impact, for papers by Lili Lu Breakdown of academic impact, for papers by Mohammed Safi
Rankless by CCL
2026